Depending on their practice and specialization area, some orthopaedists need to be “sometimes” oncologists when they are responsible for bone metastasis management. For these specialists, it pays to be familiar with recent advances in bone metastasis treatment and to know when their patients’ metastasis is the initial presentation of an unknown cancer.
In the cover story article in the June issue ofOrthopaedics Today Europe, European orthopaedists discuss the problem of pathological fractures, the use of multi-modal therapy and newer techniques of note, including bone-targeted agents and drugs that inhibit osteoclast formation, function and survival.
